STAPLOE MEDICAL CENTRE — All Prescriptions & Medications — Page 4
Practice Code: D81014 | ELY, CB7 5JD
Showing results 151-200 of 706
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 537 | 83.6K | £2.7K | +94.2% ▲ | |
| Clarithromycin | 532 | 11.2K | £2.5K | +116.8% ▲ |
| Betamethasone esters | 530 | 20.9K | £3.8K | +778.5% ▲ |
| Calcipotriol | 527 | 39.6K | £22.5K | +209.6% ▲ |
| Nifedipine | 524 | 24.2K | £4.5K | +179.6% ▲ |
| Lactulose | 518 | 294.0K | £2.7K | +57.3% ▲ |
| Sodium valproate | 512 | 71.9K | £6.4K | +61.0% ▲ |
| Aciclovir | 507 | 22.6K | £1.0K | +240.9% ▲ |
| Insulin detemir | 502 | 2,891 | £23.7K | +541.0% ▲ |
| Clobetasone butyrate | 497 | 19.8K | £5.0K | +143.5% ▲ |
| Olmesartan medoxomil | 469 | 13.1K | £624 | +580.7% ▲ |
| Insulin glargine | 467 | 1,968 | £16.8K | +64.5% ▲ |
| Docusate sodium | 461 | 30.7K | £2.2K | +24.3% ▲ |
| Loperamide hydrochloride | 460 | 42.6K | £1.4K | +97.5% ▲ |
| Formoterol/glycopyrronium/budesonide | 455 | 455 | £18.8K | +655.6% ▲ |
| 452 | 68.3K | £3.4K | -4.7% ▼ | |
| Nebivolol | 441 | 13.8K | £3.0K | +316.0% ▲ |
| Risperidone | 441 | 17.2K | £5.5K | +74.3% ▲ |
| Tolterodine | 433 | 13.8K | £2.3K | +191.2% ▲ |
| Lymecycline | 432 | 12.5K | £1.5K | +259.2% ▲ |
| Prochlorperazine maleate | 430 | 19.2K | £1.0K | +112.7% ▲ |
| Trimethoprim | 427 | 20.8K | £1.1K | +109.0% ▲ |
| Celecoxib | 427 | 20.2K | £1.5K | +546.6% ▲ |
| Etoricoxib | 425 | 8,604 | £2.0K | +427.5% ▲ |
| Combined ethinylestradiol 30mcg | 424 | 66.4K | £3.6K | +52.7% ▲ |
| Azathioprine | 424 | 23.4K | £548 | +291.2% ▲ |
| Hypromellose | 421 | 5,120 | £1.2K | +217.7% ▲ |
| Buprenorphine | 410 | 1,938 | £9.5K | +11.9% ▲ |
| Empagliflozin | 405 | 8,843 | £10.8K | -35.3% ▼ |
| Diclofenac diethyl | 405 | 45.3K | £3.1K | +14.1% ▲ |
| Fluticasone propionate (Nasal) | 397 | 1,281 | £4.7K | +172.7% ▲ |
| Aripiprazole | 394 | 12.4K | £1.8K | +54.8% ▲ |
| Sulfasalazine | 393 | 42.3K | £7.0K | +201.9% ▲ |
| Fluconazole | 383 | 3,056 | £884 | +395.4% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 377 | 15.8K | £1.2K | +146.8% ▲ |
| Sacubitril/valsartan | 369 | 18.7K | £29.5K | +54.1% ▲ |
| Betahistine hydrochloride | 364 | 28.7K | £1.0K | +52.5% ▲ |
| Clotrimazole | 363 | 8,200 | £514 | +274.6% ▲ |
| Letrozole | 362 | 9,219 | £866 | +93.9% ▲ |
| Dexamethasone | 361 | 1,925 | £1.2K | +109.9% ▲ |
| 358 | 182.3K | £1.3K | +292.6% ▲ | |
| Hyoscine butylbromide | 357 | 33.8K | £2.3K | +53.2% ▲ |
| Carvedilol | 345 | 15.5K | £603 | +204.0% ▲ |
| Clonazepam | 345 | 13.9K | £1.8K | +121.4% ▲ |
| Insulin degludec | 342 | 1,705 | £19.3K | +211.2% ▲ |
| Risedronate sodium | 342 | 1,368 | £368 | +181.9% ▲ |
| Aclidinium bromide/formoterol | 338 | 338 | £10.2K | +861.4% ▲ |
| Lorazepam | 332 | 6,367 | £1.8K | +132.9% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 328 | 24.3K | £1.9K | +45.1% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 323 | 44.7K | £3.1K | +113.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.